Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease

Respiration

Volumn 81, Issue 6, 2011, Pages 476-482

  Schirnhofer, Lea ^a   Lamprecht, Bernd ^a   Firlei, Natalie ^a   Kaiser, Bernhard ^a   Buist, A Sonia ^b   Halbert, Ronald J ^d   Allison, Michael J ^c   Studnicka, Michael ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Airway obstruction; Chronic obstructive pulmonary disease; Non diagnosed airway obstruction; Spirometry

Indexed keywords

SALBUTAMOL;

ADULT; AGED; AIRWAY OBSTRUCTION; ANAMNESIS; ARTICLE; AUSTRIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPIROMETRY;

ADULT; AGED; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 79956101075     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000320251     Document Type: Article

References (26)

1. Scanlon PD, Connett JE, Waller LA, et al: Smoking cessation and lung function in mild-to-moderate chronic obstructive pulm onary disease. The Lung Health Study. Am J Respir Crit Care Med 2000;161:381-390. (Pubitemid 30129442)
2. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504. (Pubitemid 27216360)
3. Bilde L, Rud SA, Dollerup J, et al: The cost of treating patients with COPD in Denmark - a population study of COPD patients compared with non-COPD controls. Respir Med 2007;101:539-546. (Pubitemid 46196322)
4. Lopez AD, Shibuya K, Rao C, et al: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412. (Pubitemid 43180921)
5. Talamo C, de Oca MM, Halbert R, et al: Diagnostic labeling of COPD in five Latin American cities. Chest 2007;131:60-67. (Pubitemid 46122975)
6. Coultas DB, Mapel D, Gagnon R, et al: The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001;164:372-377. (Pubitemid 32778201)
7. Pena VS, Miravitlles M, Gabriel R, et al: Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-989.
8. Halbert RJ, Natoli JL, Gano A, et al: Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-532. (Pubitemid 44794666)
9. Buist AS, Vollmer WM, Sullivan SD, et al: The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277-283. (Pubitemid 40993302)
10. Buist AS, McBurnie MA, Vollmer WM, et al: International variation in the prevalence of COPD (the BOLD Study): a populationbased preva lence study. Lancet 2007;370:741-750. (Pubitemid 47321907)
11. Schermer TR, Smeele IJ, Thoonen BP, et al: Current clinical guideline definitions for airf low obstruction leads to substantial overdiagnosis of COPD in primary care. Eur Respir J 2008;32:945-952.
12. Gläser S, Schäper C, Obst A, et al: Impact of different definitions of airflow limitation on the prevalence of chronic obstructive pulmonary disease in the general population. Respiration 2010;80:292-300.
13. Pellegrino R, Viegi G, Brusasco V, et al: Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-968. (Pubitemid 41632054)
14. Vollmer WM, Gislason T, Burney P, et al: Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009;34:588-597.
15. Rabe KF, Hurd S, Anzueto A, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555. (Pubitemid 47403272)
16. Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). Chest 1998;113(2 suppl):123S-163S.
17. O'Donnell DE, Hernandez P, Kaplan A, et al: Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008;15(suppl A): 1A-8A. (Pubitemid 351566057)
18. U. S. Preventive Services Task Force: Screening for chronic obstructive pulmonary disease using spirometry: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148:529-534.
19. Schirnhofer L, Lamprecht B, Vollmer WM, et al: COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest 2007;131:29-36. (Pubitemid 46122971)
20. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-1136.
21. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U. S. population. Am J Respir Crit Care Med 1999;159:179-187. (Pubitemid 29036522)
22. Lindberg A, Bjerg A, Ronmark E, et al: Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006;100:264-272. (Pubitemid 43078978)
23. Vestbo J, Lange P: Can GOLD stage0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002;166:329-332. (Pubitemid 34864421)
24. Derom E, van WC, Liistro G, et al: Primary care spirometry. Eur Respir J 2008;31:197-203.
25. Leuppi JD, Miedinger D, Chhajed PN, et al: Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration 2010;79:469-474.
26. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2007. http://www.goldcopd.org.